Cost of severe asthma in Brazil—systematic review

References

• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention, revised 2014 [cited 2014 Jun 1st]. Available from: http://www.ginasthma.org/local/uploads/files/GINA_Report_2014_Aug12.pdf.
   Google Scholar
• Novak N, Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 2003; 112(2): 252–262.
   PubMed Web of Science ®Google Scholar
• Braman SS. The Global Burden of Asthma. Chest 2006;130:4S–12S.
   PubMed Web of Science ®Google Scholar
• Sociedade Brasileira de Pneumologia e Tisiologia (SBPT). Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia para o Manejo da Asma - 2012. J Bras Pneumol 2012; 38 (Suppl 1):S1–S46. In Portuguese.
   Google Scholar
• Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, et al. A new perspective on concepts of asthma severity and control. Eur Respir J 2008;32(3):545–554.
   PubMed Web of Science ®Google Scholar
• Sociedade Brasileira de Pneumologia e Tisiologia. IV Diretrizes Brasileiras para o Manejo da Asma. J Bras Pneumol 2006;32(Supl 7):S447–S74. In Portuguese.
   Google Scholar
• Antonicelli L, Bucca C, Neri M, De Benedetto F, Sabbatani P, Bonifazi F, et al. Asthma severity and medical resource utilisation. Eur Respir J 2004; 23(5):723–729.
   PubMed Web of Science ®Google Scholar
• Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Resp Crit Care Med 1997;156:787–793.
   PubMed Web of Science ®Google Scholar
• Brasil. Ministério da Saúde. Secretaria da Atenção a Saúde (SAS/MS). Portaria SAS/MS n° 12, de 12 de novembro de 2002. Protocolo Clinico e Diretrizes Terapêuticas Asma Grave [Internet]. 2002;109–14. Available from: http://www.itarget.com.br/newclients/sppt.org.br/2010/extra/download/protocolo_asma.pdf [last accessed 9 Oct 2013]. In Portuguese.
   Google Scholar
• Adcock IM, Caramori G, Chung KF. New targets for drug development in asthma. Lancet 2008;372(9643):1073–1087.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Bousquet PJ, Godard P, Daures JP. The public health implications of asthma. Bull World Health Organ 2005;83(7):548–554.
   PubMed Web of Science ®Google Scholar
• Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Br Med J 2013; 346:1.
   Web of Science ®Google Scholar
• Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. Br Med J 1996;313:275–283.
   PubMed Web of Science ®Google Scholar
• Stuhldreher N, Konnopka A, Wild B, Herzog W, Zipfel S, Löwe B, König HH. Cost-of-illness studies and cost-effectiveness analyses in eating disorders: a systematic review. Int J Eat Disord 2012;45(4):476–491.
   PubMed Web of Science ®Google Scholar
• Kleine-Budde K, Touil E, Moock J, Bramesfeld A, Kawohl W, Rössler W. Cost of illness for bipolar disorder: a systematic review of the economic burden. Bipolar Disord 2014;16(4):337–353.
   PubMed Web of Science ®Google Scholar
• Banco Central do Brasil (BACEN). Taxas de câmbio. Available from:http://www4.bcb.gov.br/pec/taxas/batch/taxas.asp?id=txdolar.. [last accessed 24 June 2015]. In Portuguese.
   Google Scholar
• Instituto Brasileiro de Geografia e Estatística (IBGE). Sistema Nacional de Índices de Preços ao Consumidor. Séries históricas. Available from: http://www.ibge.gov.br/home/estatistica/indicadores/precos/inpc_ipca/defaultseriesHist.shtm. [last accessed 24 June 2015]. In Portuguese.
   Google Scholar
• Santos LA, Oliveira MA, Faresin SM, Santoro IL, Fernandes ALG. Direct costs of asthma in Brazil: a comparison between controlled and uncontrolled asthmatic patients. Braz J Med Biol Res 2007;40(7):943–8.
   PubMed Web of Science ®Google Scholar
• Franco R, Santos AC, Nascimento HF, Souza-Machado C, Ponte E, Souza-Machado A, et al. Cost-effectiveness analysis of a state funded programme for control of severe asthma. BMC Public Health 2007;7:82.
   PubMed Web of Science ®Google Scholar
• Franco R, Nascimento HF, Cruz AA, Santos AC, Souza-Machado C, Ponte E V, et al. The economic impact of severe asthma to low-income families. Allergy 2009;64(3):478–83.
   PubMed Web of Science ®Google Scholar
• Paim J, Travassos C, Almeida C, Bahia L, Macinko J. The Brazilian health system: history, advances, and challenges. Lancet 2011; 377(9779):1778–97.
   PubMed Web of Science ®Google Scholar
• Pietrobon L, Prado ML do, Caetano JC. Saúde suplementar no Brasil: o papel da Agência Nacional de Saúde Suplementar na regulação do setor. Physis Rev Saúde Coletiva 2008;18(4):767–783.
   Google Scholar
• Brasil. Ministério da Saúde. Conselho Nacional de Secretários de Saúde. Regulação em Saúde. Brasilia: CONASS; 2007.
   Google Scholar
• Brasil. Ministério da Saúde. Conselho Nacional de Secretários de Saúde. Saúde Suplementar. Brasília: CONASS; 2007.
   Google Scholar
• Brasil. Ministério da Saúde. Portal de Saúde. Programa Farmácia Popular do Brasil. Available from: http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/leia-mais-o-ministerio/346-sctie-raiz/daf-raiz/farmacia-popular/l1-farmacia-popular/18008-programa-farmacia-popular-do-brasilpdf [last accessed 30 Dec 2015]. In Portuguese.
   Google Scholar
• Sociedade Brasileira de Pneumologia e Tisiologia (SBPT). Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia para o Manejo da Asma - 2012. J Bras Pneumol 2012;38 (Suppl 1):S1–S46.
   Google Scholar
• Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde (SAS/MS). Protocolo Clínico e Diretrizes Terapêuticas da Asma. Portaria SAS/MS n° 1.317, de 25 de novembro de 2013 e atualizado pela Portaria SAS/MS n° 603, de 21 de julho de 2014.
   Google Scholar
• Brasil. Ministério da Saúde. DATASUS. Informações de saúde, TABNET. Available from: http://www2.datasus.gov.br/DATASUS/index.php?area=02.acce [last accessed 13 August 2015]. In Portuguese.
   Google Scholar
• Rascati KL. Medindo e estimando custos. In: Rascati KL. Introdução à farmacoeconomia. Ed. Brasileira, Artmed, Porto Alegre, Brasil, 2010; 29–44. In Portuguese.
   Google Scholar
• Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL Cost analysis. In: Drummond MF, et al. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, 2005;55–102.
   Google Scholar
• Haddix A, Teutsch S, Corso P. Costs. In: Haddix A, Corso P, Gorsky R. Guide to decision analysis and economic evaluation. London: Oxford University Press, 2003;53–76.
   Google Scholar
• Oliveira M, Santos L, Silva E. Bases metodológicas para estudos de custos da doença no Brasil. Rev Nutr 2014;27(5):585—595.
   Google Scholar
• Brasil. Ministério da Saúde. SIGTAP-Sistema de Gerenciamento da Tabela de Procedimentos, Medicamentos e OPM do SUS. Available from: http://sigtap.datasus.gov.br/tabela-unificada/app/sec/inicio.jsp [last accessed 28 December 2015]. In Portuguese.
   Google Scholar
• Romano M, Machnicki G, Rojas JI, Frider N, Correale J. There is much to be learnt about the costs of multiple sclerosis in Latin America. Arq Neuropsiquiatr 2013;71(8):549–555.
   PubMed Web of Science ®Google Scholar
• Neffen H, Gonzalez SN, Fritscher CC, Dovali C, Williams AE. The burden of unscheduled health care for asthma in Latin America. J Investig Allergol Clin Immunol 2010;20(7):596–601.
   PubMed Web of Science ®Google Scholar
• Garcia LP, Sant'Anna AC, Magalhães LCG, Freitas LRS, Aurea AP. Gastos das famílias brasileiras segundo a renda familiar: análise da Pesquisa de Orçamentos Familiares de 2002–2003 e de 2008–2008. Cad Saúde Pública 2013;29(8):1605–1616.
   PubMed Web of Science ®Google Scholar